Ardea Biosciences (RDEA) Lower Following Pricing of 8.5M Common Offering
Down)
Ardea Biosciences, Inc. (Nasdaq: RDEA) shares are over 5 percent lower early following pricing of its 8.5 million common stock offering. The firm priced the shares at $17 each, a discount of 6.5 to Tuesday's closing of $18.19.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
You May Also Be Interested In
- Savient Pharma (SVNT) Moves Higher with Volatility; Bumps Up Against Key Resistance Point
- Facebook (FB) Warned You About Weak Q2 Three Times
- Maastricht Treaty to Blame for Crisis in EU...
Create E-mail Alert Related Categories
Equity Offerings, Insiders' BlogSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
